A novel once-daily oral PCSK9 inhibitor lowered LDL by up to 60% at 24 weeks in patients with heart disease or at high risk ...
Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha ® ...
Leqvio (inclisiran) is a prescription drug used to help treat certain types of high cholesterol. Leqvio comes in a prefilled syringe for injection under the skin. Leqvio contains the active drug ...
Repatha VESALIUS-CV Trial Met Dual Primary Endpoints Demonstrating Reduction in CV Events in High-Risk Patients Who Have Never Had a Heart Attack or Stroke Real-World Evidence from the Repatha-CE ...
OpenAI unveiled its Atlas AI browser this week, and it’s already catching heat. Cybersecurity researchers are particularly alarmed by its integrated “agent mode,” currently limited to paying ...
Hosted on MSN
Sourdough bread making with instructions
7 lions to be euthanized at wildlife park: "No real options left" Trump Considers National Emergency Over State Elections Chainsaw recalled nationwide from Home Depot—"Immediately stop using" Vanessa ...
Leqvio (inclisiran) may cause injection site reactions, including bruising, pain, discoloration, itchiness, and a burning or prickling sensation at the injection site. In addition to injection site ...
Don't miss out on our latest stories. Add PCMag as a preferred source on Google. AI-powered browsers are supposed to be smart. However, new security research suggests that they can also be weaponized ...
AmgenAMGN crushed third-quarter expectations late Tuesday, thanks to big sales beats from blockbuster drugs Repatha and Prolia. Revenue from cholesterol treatment Repatha surged 40% to $794 million, ...
Women get a bigger health boost from exercise than men Women only need to exercise half as much as men to get similar benefits Women experience a three-fold reduction in their risk of death from heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results